| 10507201 |
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors |
Nicole Buschmann, Robin Alec Fairhurst, Pascal Furet, Diana Graus Porta, Carolina Haefliger +14 more |
2019-12-17 |
$17,613,000 |
| 8097621 |
Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors |
Andrew Simon Bell, David Brown, Kevin Dack, David Nathan Abraham Fox, Ian Roger Marsh +2 more |
2012-01-17 |
$303,869,000 |
| 7902195 |
Pyridine [3,4-b] pyrazinones |
Robert Owen Hughes, Andrew Simon Bell, David Brown, Dafydd Rhys Owen, Christopher Phillips +12 more |
2011-03-08 |
|
| 7572799 |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
Andrew Simon Bell, David Brown, Kevin Neil Dack, David Nathan Abraham Fox, Ian Roger Marsh +2 more |
2009-08-11 |
$271,217,000 |
| 7569572 |
Pyrazolo[4,3-D]pyrimidines |
Andrew Simon Bell, David Brown, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell +4 more |
2009-08-04 |
$282,206,000 |
| 7262192 |
Substituted pyrazolo[4,3-d]pyrimidines and their use as PDE-5 inhibitors |
Andrew Simon Bell, David Brown, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell +1 more |
2007-08-28 |
$346,493,000 |
| 6686357 |
FKBP inhibitors |
Martin James Wythes, Mark Ian Kemp, Malcolm C. MacKenny, Robert John Maguire, James F. Blake |
2004-02-03 |
$271,315,000 |
| 6610707 |
Heterocyclic compounds as inhibitors of rotomase enzymes |
David John Bull, Robert John Maguire, Martin James Wythes |
2003-08-26 |
$177,412,000 |
| 6562964 |
Heterocyclic compounds as inhibitors of rotamase enzymes |
Mark Ian Kemp, Mark Sanner, Martin James Wythes |
2003-05-13 |
$363,321,000 |
| 6509464 |
FKBP inhibitors |
Martin James Wythes, Mark Ian Kemp, Malcolm C. MacKenny, Robert John Maguire, James F. Blake |
2003-01-21 |
$455,582,000 |
| 6495549 |
FKBP inhibitors |
Martin James Wythes, Mark Ian Kemp, Malcolm C. MacKenny, Robert John Maguire, James F. Blake |
2002-12-17 |
$317,881,000 |
| 6372736 |
Heterocyclic compounds as inhibitors of rotamase enzymes |
Mark Ian Kemp, Mark Sanner, Martin James Wythes |
2002-04-16 |
$246,300,000 |
| 6166011 |
FKBP inhibitors |
Martin James Wythes, Mark Ian Kemp, Malcolm C. MacKenny, Robert John Maguire, James F. Blake |
2000-12-26 |
$335,411,000 |
